Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-407

Overview: Join us as we review the risks and benefits of contraceptive options, focusing on levonorgestrel intrauterine devices (IUDs) and their potential link to breast cancer risk. Hear the data and key considerations to help patients make informed decisions, balancing benefits and risks effectively in your primary care practice.

Episode resource links:

• Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. Published online October 16, 2024. doi:10.1001/jama.2024.18575
• https://www.nytimes.com/2024/10/16/well/iud-breast-cancer-mirena-skyla.html?smid=url-share

Guest: Jillian Joseph, PA-C
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-406

Overview: An increasing number of therapies are being formulated for nasal delivery. This episode reviews the use of 3 of these therapies: at-home flu vaccines, epinephrine for allergic reactions, and saline nasal sprays for the common cold. Hear how these newly available treatments can increase options for care in your clinical practice.

Episode resource links:

• Flu Vaccine: Vaccine. 2015 Jul 31;33(32):3894-9.  doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.
• Nasal Saline: https://k4.ersnet.org/prod/v2/Front/Program?e=549
• Nasal Epinephrine: https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis

Guest: Robert A. Baldor MD, FAAFP 

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405

Overview: Explore the American Heart Association’s (AHA) newly validated risk calculator, designed to assess the likelihood of cardiovascular disease and heart failure in patients aged 30-79 years. Hear which risk factors are included, why they matter, and how this tool can enhance your preventive care strategies in primary care practice.

Episode resource links:

• Hypertension. 2024;81:00–00. DOI: 10.1161/HYPERTENSIONAHA.124.22998.)
• https://doi.org/10.1161/CIRCULATIONAHA.123.067626
• The calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

Guest: Robert A. Baldor MD, FAAFP 

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-405

Overview: It’s estimated that between 40%-60% of women report some degree of sexual dysfunction, which can have a significant impact on an individual’s quality of life and personal relationships. Even though most clinicians understand the importance and relevance of female sexual dysfunction (FSD), they may not be aware of its prevalence, effective treatments, or how best to inquire about it. Join us as we discuss this condition, its impact on women, and evidence on effective treatments.

Episode resource links:

• Cristine Homsi Jorge, Kari Bø, Camila Chiazuto Catai, Luiz Gustavo Oliveira Brito, Patricia Driusso, Merete Kolberg Tennfjord. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. Volume 231, Issue 1, 2024,Pages 51-66.e1,ISSN 0002-9378, https://doi.org/10.1016/j.ajog.2024.01.001.(https://www.sciencedirect.com/science/article/pii/S0002937824000061)
• Davis, SR. Sexual dysfunction in women. New England Journal of Medicine. V 391. N 8; P 736-745. https://www.nejm.org/doi/full/10.1056/NEJMcp2313307
• Johnson, Isabella MS; Thurman, Andrea Ries MD; Cornell, Katherine A. BS; Hatheway, Jessica MBA; Dart, Clint MS; Brainard, C. Paige MD; Friend, David R. PhD; Goldstein, Andrew MD. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics & Gynecology ():10.1097/AOG.0000000000005648, June 18, 2024. | DOI: 10.1097/AOG.0000000000005648
• Kamrul-Hasan, A.B.M, Hannan, M A A, Muhammad S, M, Aalpona, Fatema, T Z, Nagendra, L., Selim, S,  Dutta, D, D. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Medicine 103(25):p e38592, June 21, 2024. | DOI: 10.1097/MD.0000000000038592
• Yao H, Zhang X, Sun F, Tang G, Wu J, Zhou Z. The efficacy of intravaginal electrical stimulation (IVES) in treating female with urinary incontinence symptom from meta-analysis of nine randomized controlled trials. Front Neurol. 2022;13:933679. Published 2022 Sep 13. doi:10.3389/fneur.2022.933679
• Huang H, Ding G, Li M, Deng Y, Cheng Y, Jin H.(2023) Menopause and stress urinary incontinence: The risk factors of stress urinary incontinence in perimenopausal and postmenopausal women. J Obstet Gynaecol Res. 49(10): 2509–2518. https://doi.org/10.1111/jog.15742
• Tunn, R., Baessler, K., Knüpfer, S., & Hampel, C. (2023). Urinary Incontinence and Pelvic Organ Prolapse in Women. Deutsches Arzteblatt international, 120(5), 71–80. https://doi.org/10.3238/arztebl.m2022.0406

Guest: Susan Feeney, DNP, FNP-BC, NP-C, Jill M. Terrien, PhD, ANP-BC

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-403

Overview: Recorded live at Pri-Med East! - The American Diabetes Association (ADA) has updated their standards of care for patients with diabetes. In this episode, we discuss some of the changes in the initial selection of glucose-lowering medications for type 2 diabetes mellitus (T2DM), including when alternatives to metformin may be appropriate. Hear strategies for making personalized, guideline-recommended choices that enhance care for patients with T2DM.

Episode resource links:

• Pharmacologic Approaches to Glycemic Treatment. In: American Diabetes Association. Standardsof Care in Diabetes2024 - DiabetesCare 2024 Jan 1;47(Suppl 1):S1-S321

Guest: Alan M. Ehrlich, MD, FAAFP 

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

This podcast will shed light on the prevalence and significance of post-traumatic stress disorder (PTSD) in the non-veteran population of the United States, with a particular focus on the unique aspects of PTSD in women compared to those in men.

References and Resources

1. American Psychiatric Association. What is posttraumatic stress disorder (PTSD)? Accessed October 4, 2024. https://www.psychiatry.org/patients-families/ptsd/what-is-ptsd.
2. Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Substance Abuse and Mental Health Services Administration (US); 2014. (Treatment Improvement Protocol (TIP) Series, No. 57.) Exhibit 1.3-4. https://www.ncbi.nlm.nih.gov/books/NBK207191/box/part1_ch3.box16/
3. Davis LL, Schein J, Cloutier M, et al. The economic burden of posttraumatic stress disorder in the United States from a societal perspective. J Clin Psychiatry. 2022;83(3):21m14116. doi:10.4088/JCP.21m14116
4. Husarewycz MN, El-Gabalawy R, Logsetty S, Sareen J. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry. 2014;36(1):26-32. doi: 10.1016/j.genhosppsych.2013.06.003
5. National Institute of Mental Health. Post-traumatic stress disorder (PTSD). Accessed October 4, 2024. https://www.nimh.nih.gov/health/statistics/post-traumatic-stress-disorder-ptsd
6. Olff M, Willemien L. Why men and women may respond differently to psychological trauma. Psychiatric Times. Accessed October 4, 2024. https://www.psychiatrictimes.com/view/why-men-and-women-may-respond-differently-to-psychological-trauma
7. PTSD: National Center for PTSD. PTSD basics. U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/understand/what/ptsd_basics.asp
8. PTSD: National Center for PTSD. PTSD checklist for DSM-5 (PCL-5). U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp
9. Ramos N, Marr MC. Traumatic stress and resilience among transgender and gender diverse youth. Child Adolesc Psychiatr Clin N Am. 2023;32(4):667-682. doi:10.1016/j.chc.2023.04.001
10. Tobin-Tyler E, Dickman SL. Rape, homicide, and abortion bans—the abandonment of people subjected to sexual and intimate partner violence. N Engl J Med. 2024;391(4):289-292. doi:10.1056/NEJMp2405254
11. Vogt D. Research on women, trauma, and PTSD. U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/professional/treat/specific/ptsd_research_women.asp
12. Wang Y, Chung MC, Wang N, Yu X, Kenardy J. Social support and posttraumatic stress disorder: a meta-analysis of longitudinal studies. Clin Psychol Rev. 2021;85:101998. doi.org/10.1016/j.cpr.2021.101998
13. World Health Organization. Post-traumatic stress disorder. Accessed October 4, 2024. https://www.who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-402

Overview: Some blood pressure medications have been found to cause adverse side effects in older adults, such as itchy skin and an increased risk of stroke. Join us as we cover 2 recent publications that add clinical implications to which blood pressure medications we use. Come away feeling confident to improve hypertension outcomes in older patients.

Episode resource links:

• JAMA Dermatol. Published online May 22, 2024. doi:10.1001/jamadermatol.2024.1230
• JAMA Netw Open. 2023;6(12):e2344998. doi:10.1001/jamanetworkopen.2023.44998

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401

Overview: Evidence has shown that exercise can improve mood, but how successful is it for treating depression compared to other therapies? What types and intensities are most effective? Discover insights from a recent meta-analysis on the effects of exercise on depression and strategies to promote it in those with major depression.

Episode resource links:

• Noetel M, Sanders T, Gallardo-Gómez D, Taylor P, del Pozo Cruz B, van den Hoek D et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials BMJ 2024; 384 :e075847 doi:10.1136/bmj-2023-075847
• Vancampfort, D., Hallgren, M., Firth, J., Rosenbaum, S., Schuch, F. B., Mugisha, J., Probst, M., Van Damme, T., Carvalho, A. F., & Stubbs, B. (2017). Physical activity and suicidal ideation: a systematic review and meta-analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2017.08.070

Guest: Susan Feeney, DNP, FNP-BC, NP-C

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-400

Overview: The FDA recently approved primary human papillomavirus (HPV) self-collection for cervical cancer screening in a healthcare setting. Join us as we explore how to counsel patients on this less invasive method and find out what’s on the horizon for at-home collection kits.

Episode resource links:

• https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037
• Journal of Clinical Virology, 2020-06-01, Volume 127, Article 104375, Copyright © 2020 Elsevier B.V. 
• JAMA. 2023;330(20):1971-1981. doi:10.1001/jama.2023.21471

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399

Overview: In this episode, we look at a new study showing increased probability of survival for patients with Alzheimer disease (AD) who take donepezil and memantine together. We review current treatments for AD and address common hesitations in prescribing dual pharmacotherapy, providing vital insights for primary care clinicians.

Episode resource links:

• Yaghmaei, E., Lu, H., Ehwerhemuepha, L. et al. Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients.Commun Med 4, 99 (2024). https://doi.org/10.1038/s43856-024-00527-6
• Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis. Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10. PMID: 32914577; PMCID: PMC7667299.

Guest: Jillian Joseph, MPAS, PA-C

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.50 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/ask-the-expert-about-pain-management 

Overview:

In this podcast, Dr. Katherine Galluzzi answers several of the frequently asked questions regarding pain management, such as the use of NSAIDs in patients with cardiovascular disease, the effects of long-term opioid therapy, practical approaches to initiating buprenorphine, and whether or not a Patient Provider Agreement is necessary for patients in hospice care. 

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).